ABROCITINIB - Food and Drug Administration

Manufacturer: Food and Drug Administration
Effective date: 2022-09-28
Label type: Indexing - product concept
Version: 1
Source: full-release
Hydrated at: 2026-06-05 00:20:24

Label at a glance#

ProductABROCITINIB

Active ingredientABROCITINIB

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 1 matching rows.

ABROCITINIB

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ABROCITINIB	73SM5SF3OR	ACTIB
ABROCITINIB	73SM5SF3OR	ACTIB
ABROCITINIB	73SM5SF3OR	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cibinqo	ABROCITINIB	Pfizer Laboratories Div Pfizer Inc	3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258	2026-09-09	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ABROCITINIB
CIBINQO	ABROCITINIB	U.S. Pharmaceuticals	16c12a56-4550-414b-ac9d-b785b41fea6b	2026-07-09	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ABROCITINIB

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.